miR‐375 controls porcine pancreatic stem cell fate by targeting 3‐phosphoinositide–dependent protein kinase‐1 <i>(Pdk1)</i>
Shuxian Hu(Northwest A&F University), Sha Peng(North West Agriculture and Forestry University), Fen Sun(Chinese Academy of Sciences), Xin He(Sun Yat-sen University), Jinlian Hua(North West Agriculture and Forestry University), Mingzhi Zhang(Chinese Academy of Sciences), Lipeng Ren(Northwest A&F University)
Cited by 20
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134